252 related articles for article (PubMed ID: 30111348)
1. Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms.
Kwiecinska K; Strojny W; Pietrys D; Bik-Multanowski M; Siedlar M; Balwierz W; Skoczen S
Ital J Pediatr; 2018 Aug; 44(1):92. PubMed ID: 30111348
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia.
Skoczen S; Tomasik PJ; Bik-Multanowski M; Surmiak M; Balwierz W; Pietrzyk JJ; Sztefko K; Gozdzik J; Galicka-Latała D; Strojny W
J Exp Clin Cancer Res; 2011 Jun; 30(1):64. PubMed ID: 21631924
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia.
Veringa SJ; van Dulmen-den Broeder E; Kaspers GJ; Veening MA
Pediatr Blood Cancer; 2012 Feb; 58(2):278-82. PubMed ID: 21793179
[TBL] [Abstract][Full Text] [Related]
4. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.
Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
[TBL] [Abstract][Full Text] [Related]
7. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Salo J; Lanning M; Vilkkumaa I; Harila-Saari AH
Pediatr Blood Cancer; 2010 Aug; 55(2):331-6. PubMed ID: 20582965
[TBL] [Abstract][Full Text] [Related]
8. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL
J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534
[TBL] [Abstract][Full Text] [Related]
10. Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
Szymon S; Bik-Multanowski M; Balwierz W; Pietrzyk JJ; Surmiak M; Strojny W; Galicka-Latala D; Gozdzik J
J Genet; 2011 Aug; 90(2):365-8. PubMed ID: 21869491
[No Abstract] [Full Text] [Related]
11. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia.
Elitzur S; Houri-Shtrecher R; Yackobovitz-Gavan M; Avrahami G; Barzilai S; Gilad G; Lebenthal Y; Phillip M; Stark B; Yaniv I; Shalitin S
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):869-877. PubMed ID: 28742520
[TBL] [Abstract][Full Text] [Related]
12. [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia].
Skoczeń S; Tomasik P; Balwierz W; Surmiak M; Sztefko K; Galicka-Latała D
Przegl Lek; 2011; 68(9):592-6. PubMed ID: 22335007
[TBL] [Abstract][Full Text] [Related]
13. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.
Marcoux S; Drouin S; Laverdière C; Alos N; Andelfinger GU; Bertout L; Curnier D; Friedrich MG; Kritikou EA; Lefebvre G; Levy E; Lippé S; Marcil V; Raboisson MJ; Rauch F; Robaey P; Samoilenko M; Séguin C; Sultan S; Krajinovic M; Sinnett D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27917589
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
Krull KR; Brinkman TM; Li C; Armstrong GT; Ness KK; Srivastava DK; Gurney JG; Kimberg C; Krasin MJ; Pui CH; Robison LL; Hudson MM
J Clin Oncol; 2013 Dec; 31(35):4407-15. PubMed ID: 24190124
[TBL] [Abstract][Full Text] [Related]
15. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.
Benadiba J; Michel G; Auquier P; Chastagner P; Kanold J; Poirée M; Plantaz D; Padovani L; Berbis J; Barlogis V; Contet A; Chambost H; Sirvent N
J Pediatr Hematol Oncol; 2015 Mar; 37(2):109-16. PubMed ID: 24936742
[TBL] [Abstract][Full Text] [Related]
16. Lower quality of life in young men after pediatric kidney transplantation when compared to healthy controls and survivors of childhood leukemia-a cross-sectional study.
Endén K; Tainio J; Jalanko H; Jahnukainen K; Jahnukainen T
Transpl Int; 2018 Feb; 31(2):157-164. PubMed ID: 28850735
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
19. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
[TBL] [Abstract][Full Text] [Related]
20. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
